AAO 2024 Insights
AAO 2024 Insights: CALM - Thirty-six-Month Safety Outcomes With the 0.18mg Intravitreal FAc Implant for Noninfectious Uveitis
By
AAO 2024 Insights
FEATURING
Michael Singer
By
AAO 2024 Insights
FEATURING
Michael Singer
Comments 1
Login to view comments.
Click here to Login
